A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases
Clinical trial NCT07333118 · RECRUITING
Trial details
- NCT number
- NCT07333118
- Sponsor
- Grit Biotechnology
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-07
- Primary completion
- 2028-03-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.